SAN DIEGO--(BUSINESS WIRE)--Feb. 18, 2014-- Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the company’s presentations at two upcoming investment conferences.
Illumina will webcast its presentation at the Cowen and Company 34th Annual Health Care Conference in Boston, Massachusetts, on March 5, 2014. The live webcast is scheduled to begin at 8:40 AM ET and will feature a brief overview of the company by Marc Stapley, Senior Vice President and Chief Financial Officer, followed by a question and answer session.
Illumina will also webcast its presentation at the Morgan Stanley Technology, Media & Telecom Conference in San Francisco, California, on March 6, 2014. The live webcast is scheduled to begin at 9:20 AM PT and will feature an overview of the company by Jay Flatley, CEO followed by a question and answer session.
The webcasts can be accessed in the Investor Relations section of Illumina's web site under the "Company" tab at www.illumina.com.
About Illumina
Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.
Source: Illumina, Inc.
Illumina, Inc.
Investors:
Rebecca Chambers
858-255-5243
rchambers@illumina.com
or
Media:
Jennifer Temple
858-882-6822
pr@illumina.com
